round button
Chat now

全球脂质坏死病市场 – 行业趋势和 2030 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

全球脂质坏死病市场 – 行业趋势和 2030 年预测

  • Pharmaceutical
  • Upcoming Report
  • Feb 2023
  • Global
  • 350 页面
  • 桌子數: 220
  • 图号: 60

Global Necrobiosis Lipoidica Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2023 –2030
Diagram Market Size (Base Year)
USD 4.00 Billion
Diagram Market Size (Forecast Year)
USD 6.47 Billion
Diagram CAGR
%
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

全球脂质坏死症市场,按诊断(皮肤活检、组织病理学、其他)、治疗(疗法、药物、其他)、给药途径(口服、外用、肠外、其他)、最终用户(医院、家庭护理、专科诊所、其他)、分销渠道(医院药房、网上药房、零售药房)划分 - 行业趋势和预测到 2030 年。

Necrobiosis Lipoidica 市场

Necrobiosis Lipoidica 市场分析和规模

糖尿病相关皮肤病病例的增加促进了脂性坏死病市场的发展。根据国际糖尿病联合会的数据,糖尿病在世界范围内的发病率越来越高,到 2021 年将导致 670 万人死亡。尽管脂性坏死病的病因尚不清楚,但它可能与自身免疫因素相关的血管炎症有关。此外,主要市场参与者发起的销售活动正在逐步扩大市场。  

Data Bridge Market Research 分析了 2023-2030 年预测期内类脂坏死病市场的增长率。在上述预测期内,类脂坏死病市场的预期复合年增长率约为 6.20%。2022 年市场价值为 40 亿美元,到 2030 年将增长至 64.7 亿美元。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外,Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、渠道分析、定价分析和监管框架。

Necrobiosis Lipoidica 市场范围和细分

报告指标

细节

预测期

2023 至 2030 年

基准年

2022

历史岁月

2021(可定制为 2015 - 2020)

定量单位

收入(单位:十亿美元)、销量(单位:台)、定价(美元)

涵盖的领域

诊断(皮肤活检、组织病理学、其他)、治疗(疗法、药物、其他)、给药途径(口服、外用、肠胃外、其他)、最终用户(医院、家庭护理、专科诊所、其他)、分销渠道(医院药房、网上药房、零售药房)

覆盖国家

北美洲的美国、加拿大和墨西哥、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲其他地区

涵盖的市场参与者

Kowa Pharmaceuticals America, Inc.(美国)、Senju Pharmaceutical Co.,Ltd.(日本)、Novartis AG(瑞士)、AERIE PHARMACEUTICALS, INC.(美国)、Redx Pharma Plc(英国)

市场机会

  • 糖尿病患者增多
  • Increasing Healthcare Expenditure And Government Support

Market Definition

Necrobiosis lipoidica is the rare inflammatory granulomatous skin disorder that causes collagen degeneration. The condition is closely associated with the insulin dependent diabetes though it can occur in both types of diabetes and smoking people.  The features of necrobiosis lipoidica are reddish brown area of the skin mostly occurs in lower legs, plaques, skin bacterial infection, delayed healing of wounds, skin ulcers, skin patches with shiny, thinned and prominent blood vessels and others.

Global Necrobiosis Lipoidica Market Dynamics

Drivers

  • Increasing Prevalence of Skin Infections

The increasing prevalence of skin infections is boosting the growth of the market. The most prevalent skin disease was warts (41·3%), which is followed by acne (19.2%) and contact dermatitis (15·0%). Globally, the overall point prevalence of any skin disease was 61.2%. Around 84.5 million U.S. citizens, which means one in four were impacted by skin disease. Thus, the risk of Necrobiosis Lipoidica Diabeticorum (NLD) rises in the region.

  • Rising Clinical Research Activities

There has been many start-ups that are focusing on the improvement of the market. Also, much clinical research is helping in growth of the market. For instance, Quin is using science, engineering and design to help people who take insulin make the best possible decisions. The company uses a multi-factorial approach for the management of insulin doses. Quin is building an app that correlates daily life experience with data from diabetes devices and phones, and assists people regarding the insulin intake. It can create previously unseen insights into why blood glucose fluctuates so much and inspire new approaches to treatment and research. This factor improves the market growth.

Opportunities

  • Increasing Cases of Diabetes

Around 422 million people globally have diabetes, the majority surviving in low-and middle-income countries, and 1.5 million deaths are directly related to diabetes each year. Both the number of cases and the incidence of diabetes have been progressively increasing during the last few years. Furthermore, China is the country with the highest number of diabetics, with about 141 million people suffering from the disease. By 2045, it is expected that China will have about 174 million people with diabetes. This increasing level stimulate the condition of necrobiosis lipoidica which increases the market growth. Thus, this factor helps in increasing the market growth.

  • Growing Healthcare Expenditure And Government Support

The rising incidence of cancer, the growing awareness for the disease and the associated treatment is also enhancing. Numerous government initiatives tend to provide better and more convenient treatments along with favourable reimbursement policies that are anticipated to increase the industry growth. Additionally, growing acceptance of advanced therapies is projected to drive the market.

Restraints/Challenges

  • 治疗费用增加

与药物相关的支出不断增长阻碍了市场的增长。许多口服、外用药物价格昂贵,发展中国家和欠发达国家的人们买不起。这可能导致许多患者得不到治疗。这阻碍了市场的增长。

本 necrobiosis lipoidica 市场报告详细介绍了最新发展、贸易法规、进出口分析、生产分析、价值链优化、市场份额、国内和本地市场参与者的影响,分析了新兴收入领域的机会、市场法规的变化、战略市场增长分析、市场规模、类别市场增长、应用领域和主导地位、产品批准、产品发布、地域扩展、市场技术创新。如需了解有关 necrobiosis lipoidica 市场的更多信息,请联系 Data Bridge Market Research 获取分析师简报,我们的团队将帮助您做出明智的市场决策,实现市场增长。

近期发展

  • 2022 年,巴塞利亚制药有限公司宣布了第三阶段 ERADICATE 研究的积极顶线结果,该研究评估了头孢比普在治疗由金黄色葡萄球菌 (SAB) 引起的细菌性血流感染成年患者中的作用。
  • 2022 年,Endo International PLC 的子公司 Paladin Labs Inc. 推出了 Xydalba,这是一种 30 分钟静脉 (IV) 疗法,用于治疗急性细菌性皮肤和皮肤结构感染 (ABSSSI),可以单剂量或两剂量给药。

全球脂质坏死病市场范围

类脂性坏死病市场根据皮肤活检、治疗、给药途径、最终用户和分销渠道进行细分。这些细分市场之间的增长将帮助您分析行业中增长缓慢的细分市场,并为用户提供有价值的市场概览和市场洞察,帮助他们做出战略决策,确定核心市场应用。

皮肤活检

  • 皮肤活检
  • 组织病理学
  • 其他的

治疗

  • 治疗
  • 药物
  • 其他的

给药途径

  • 口服
  • 主题
  • 肠外
  • 其他的

最终用户

  • 医院
  • 家庭护理
  • 专科诊所
  • 其他的

分销渠道

  • 医院药房
  • 网上药店
  • 零售药店

Necrobiosis Lipoidica 市场区域分析/见解

对脂质坏死病市场进行了分析,并通过上述皮肤活检、治疗、给药途径、最终用户和分销渠道提供了市场规模洞察和趋势。

necrobiosis lipoidica 市场报告涉及的主要国家 包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。

由于熟练专业人员的增加以及研发和医疗保健支出的增加,北美的脂质坏死病市场在整个预测期内一直呈现积极增长。

亚太地区因皮肤相关疾病的发病率高而占据市场主导地位。此外,医疗保健基础设施的健康改善也促进了市场的增长。

报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和国内市场监管变化。此外,在提供国家数据预测分析时,还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈竞争或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。   

竞争格局和全球 Necrobiosis Lipoidica 市场份额分析

类脂坏死病市场竞争格局提供了按竞争对手划分的详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对类脂坏死病市场的关注有关

脂质坏死病市场的主要参与者包括:

  • Kowa Pharmaceuticals America, Inc.(美国)
  • 千寿制药株式会社(日本)
  • 诺华公司(瑞士)
  • AERIE PHARMACEUTICALS, INC.(美国)
  • Redx Pharma Plc(英国)

SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The Necrobiosis Lipoidica Market is projected to grow at a CAGR of 6.20% during the forecast period by 2030.
The future market value of the Necrobiosis Lipoidica Market is expected to reach USD 6.47 billion by 2030.
The major players in the Necrobiosis Lipoidica Market are Kowa Pharmaceuticals America, Inc. (U.S.), Senju Pharmaceutical Co.,Ltd.(Japan), Novartis AG (Switzerland), AERIE PHARMACEUTICALS, INC. (U.S.), Redx Pharma Plc (U.K.).
The countries covered in the Necrobiosis Lipoidica Market are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, etc.
a